Simple Summary TERT promoter mutation has recently emerged as a promising prognostic
biomarker for aggressive papillary thyroid cancer (PTC), along with BRAF B600E mutation …

Background: Papillary thyroid cancer (PTC) has the highest cancer incidence in Korea. It is
known that some thyroid cancers have aggressive clinical behavior and a poor prognosis …

Background: The role of telomerase reverse transcriptase (TERT) promoter mutations in
differentiated thyroid cancer has been well established. These mutations have a significantly …

In this study, we examined the relationship between coexisting BRAF V600E and TERT
promoter mutations in papillary thyroid cancer (PTC) and response to therapy. PTC cases …

Background The presence of telomerase reverse transcriptase (TERT) promoter mutations
have been associated with a poor prognosis in patients with papillary thyroid carcinomas …

The role of telomerase reverse transcriptase (TERT) gene promoter mutations in the
aggressiveness of papillary thyroid cancer (PTC) remains to be further investigated. Here we …

Background: Transcriptional activating mutations of telomerase reverse transcriptase (TERT)
are associated with more aggressive thyroid cancer. We evaluated the significance of TERT …

Background The BRAF V600E and telomerase reverse transcriptase (TERT) promoter
mutations have been reported in papillary thyroid carcinoma (PTC). The aim of this …

Objective Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …

Purpose A telomerase reverse transcriptase (TERT) promoter mutation was identified in
thyroid cancer. This TERT promoter mutation is thought to be a prognostic molecular marker …